Glomerular disease workshop

Journal of the American Society of Nephrology

Volumn 16, Issue 12, 2005, Pages 3472-3476

  Meyers, Catherine M ^a   Geanacopoulos, Mark ^a   Holzman, Lawrence B ^b   Salant, David J ^c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIFIBROTIC AGENT; AUTOANTIGEN; BETA INTERFERON; BIOLOGICAL MARKER; CHEMOKINE; CHEMOKINE RECEPTOR; ECULIZUMAB; GAMMA INTERFERON; NEUTROPHIL CYTOPLASMIC ANTIBODY; PIRFENIDONE; RAPAMYCIN; RITUXIMAB; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; VASCULOTROPIN A; VASCULOTROPIN B;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CANCER; CELL INTERACTION; CLINICAL TRIAL; DRUG EFFICACY; EXPERIMENTAL MODEL; GENOMICS; GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MASS SPECTROMETRY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; GENETIC PREDISPOSITION; GENETICS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; MOLECULAR BIOLOGY; PATHOLOGY; PRACTICE GUIDELINE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; MOLECULAR BIOLOGY; PRACTICE GUIDELINES; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33645953030     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005090899     Document Type: Review

References (38)

1. US Renal Data System: USRDS 2004 Annual Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
2. Benzing T: Signaling at the slit diaphragm. J Am Soc Nephrol 15: 1382-1391, 2004
3. Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G, Benzing T: Molecular basis of the functional podocin-nephrin complex: Mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 12: 3397-3405, 2003
4. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha RL, Borner C, Pavenstadt H, Shaw AS, Walz G, Benzing T: Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23: 4917-4928, 2003
5. Huber TB, Benzing T: The slit diaphragm: A signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 14: 211-216, 2005
6. Huber TB, Kottgen M, Schilling B, Walz G, Benzing T: Interaction with podocin facilitates nephrin signaling. J Biol Chem 276: 41543-41546, 2001
7. Gerke P, Sellin L, Kretz O, Petraschka D, Zentgraf H, Benzing T, Walz G: NEPH2 is located at the glomerular slit diaphragm, interacts with nephrin and is cleaved from podocytes by metalloproteinases. J Am Soc Nephrol 16: 1693-1702, 2005
8. Wakelin SJ, Marson L, Howie SE, Garden J, Lamb JR, Forsythe JL: The role of vascular endothelial growth factor in the kidney in health and disease. Nephron Physiol 98: 73-79, 2004
9. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003
10. Eremina V, Quaggin SE: The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 13: 9-15, 2004
11. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB: Two gene fragments that direct podocyte-specific expression in transgenic mice. J Am Soc Nephrol 13: 1561-1567, 2002
12. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis. Diphtheria toxin-induced podocyte depletion in rats expressing the human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005
13. Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS: Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int 65: 129-138, 2004
14. Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS: Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 164: 786-794, 2000
15. Segerer S, Cui Y, Eitner F, Goodpaster T, Hudkins KL, Mack M, Cartron JP, Colin Y, Schlondorff D, Alpers CE: Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 37: 518-531, 2001
16. Perez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlondorff D: Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12: 1369-1382, 2001
17. Anders HJ, Frink M, Linde Y, Banas B, Wornle M, Cohen CD, Vielhauer V, Nelson PJ, Grone HJ, Schlondorff D: CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 170: 5658-5666, 2003
18. Garcia GE, Xia Y, Harrison J, Wilson CB, Johnson RJ, Bacon KB, Feng L: Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis. Am J Pathol 162: 1061-1073, 2003
19. Brouwer E, Huitema MG, Klok PA, de Weerd H, Tervaert JW, Weening JJ, Kallenberg CG: Antimyeloperoxidase-associated proliferative glomerulonephritis: An animal model. J Exp Med 177: 905-914, 1993
20. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963, 2002
21. Pendergraft WF 3rd, Preston GA, Shah RR, Tropsha A, Carter CW Jr, Jennette JC, Falk RJ: Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 10: 72-79, 2004
22. Pendergraft WF 3rd, Pressler BM, Jennette JC, Falk RJ, Preston GA: Autoantigen complementarity: A new theory implicating complementary proteins as initiators of autoimmune disease. J Mol Med 83: 12-25, 2005
23. Preston GA, Pendergraft WF 3rd, Falk RJ: New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: The theory of autoantigen complementarity. Curr Opin Nephrol Hypertens 14: 217-222, 2005
24. Hanash SM: Global profiling of gene expression in cancer using genomics and proteomics. Curr Opin Mol Ther 3: 538-545, 2001
25. Hanash S: Integrated global profiling of cancer. Nat Rev Cancer 4: 638-644, 2004
26. Jang JH, Hanash S: Profiling of the cell surface proteome. Proteomics 3: 1947-1954, 2003
27. Le Naour F, Hohenkirk L, Grolleau A, Misek DE, Lescure P, Geiger JD, Hanash S, Beretta L: Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J Biol Chem 276: 17920-17931, 2001
28. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K: Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794, 2004
29. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP: Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2: e45, 2005
30. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582, 1998
31. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349-354, 2000
32. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251-256, 2000
33. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004
34. Schmid H, Henger A, Cohen CD, Frach K, Grone HJ, Schlondorff D, Kretzler M: Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 14: 2958-2966, 2003
35. Kretzler M, Cohen CD, Doran P, Henger A, Madden S, Grone EF, Nelson PJ, Schlondorff D, Grone HJ: Repuncturing the renal biopsy: Strategies for molecular diagnosis in nephrology. J Am Soc Nephrol 13: 1961-1972, 2002
36. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffery J, Nickerson P: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15: 219-227, 2004
37. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P: Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65: 323-332, 2004
38. Schaub S, Wilkins JA, Antonovici M, Krokhin O, Weiler T, Rush D, Nickerson P: Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 5: 729-738, 2005